Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Bifunctional epoxide hydrolase 2 | ||
| Ligand | BDBM50335975 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_716998 (CHEMBL1671070) | ||
| IC50 | 300±n/a nM | ||
| Citation |  Anandan, SK; Webb, HK; Chen, D; Wang, YX; Aavula, BR; Cases, S; Cheng, Y; Do, ZN; Mehra, U; Tran, V; Vincelette, J; Waszczuk, J; White, K; Wong, KR; Zhang, LN; Jones, PD; Hammock, BD; Patel, DV; Whitcomb, R; MacIntyre, DE; Sabry, J; Gless, R 1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia. Bioorg Med Chem Lett21:983-8 (2011) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Bifunctional epoxide hydrolase 2 | |||
| Name: | Bifunctional epoxide hydrolase 2 | ||
| Synonyms: | Cytosolic epoxide hydrolase 2 | EBifunctional epoxide hydrolase 2 | EPHX2 | Epoxide hydratase | HYES_HUMAN | Lipid-phosphate phosphatase | Soluble epoxide hydrolase (sEH) | epoxide hydrolase 2, cytoplasmic | ||
| Type: | Enzyme | ||
| Mol. Mass.: | 62613.07 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | P34913 | ||
| Residue: | 555 | ||
| Sequence: |
| ||
| BDBM50335975 | |||
| n/a | |||
| Name | BDBM50335975 | ||
| Synonyms: | 1-(1-Acetyl-piperidin-4-yl)-3-(4-methyl-bicyclo[2.2.2]oct-2-yl)-urea | CHEMBL1668925 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C17H29N3O2 | ||
| Mol. Mass. | 307.4311 | ||
| SMILES | CC(=O)N1CCC(CC1)NC(=O)NC1CC2(C)CCC1CC2 |(19.45,7.01,;19.4,5.47,;18.03,4.74,;20.7,4.65,;22.06,5.37,;23.37,4.56,;23.3,3.02,;21.96,2.29,;20.65,3.11,;24.61,2.21,;24.57,.67,;23.21,-.06,;25.88,-.14,;25.86,-1.68,;26.33,-2.77,;26.12,-4.67,;26.14,-6.19,;27.5,-5.27,;27.19,-3.88,;25.83,-3.31,;24.39,-3.99,;24.61,-5.36,)| | ||
| Structure | 
| ||